Close Menu

NEW YORK (GenomeWeb) – Scottish startup Natantis said today that it has been awarded £574,000 ($724,497) by the Scottish Enterprise's High Growth Spin-Out Program  to commercialize a device for the automated extraction of cell-free DNA (cfDNA) from blood.

Natantis — founded by researchers at Heriot-Watt University — has developed the CNAsafe device, which it says can extract cfDNA from whole blood in 45 minutes for use in liquid biopsy assays.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.